Balyasny Asset Management »

Eliem Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $57k 14k 4.00

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Dr. Jeffrey R. Jay, M.D.
Sphera Funds Management
Point72 Asset Management
Driehaus Capital Management
Two Sigma Investments
Peapod Lane Capital
Nan Fung Trinity
Susquehanna International
BlackRock

View all funds holding Eliem Therapeutics